Mergers and Acquisitions

* On July 3, 2013, EP Finance, the holding company of the group founded by Eric Placet, has acquired 100% of the shares of Creapharm. This acquisition will enable to link operationally the clinical supplies activities of its subsidiary Sodia in Reims with those of Creapharm in Bordeaux. The joint capabilities of the production, packaging, distribution and expertise's of the 2 sites will further strengthen the leading group in France for pharmaceutical clinical supplies.

Eric Placet commented:" This strategic acquisition complements the offer of the Group to pharmaceutical clients, and enables us to become one of the key actors for clinical supplies in Europe. "

EP Finance currently controls 4 operational subsidiaries, Sodia - Reims (contract manufacturing and marketing of existing pharmaceutical products and clinical supplies), Stradis – Reims - (contract manufacturing of pharmaceutical products), Onyligne – Beauvais (contract development and manufacturing of cosmetic and hygiene products) and now Creapharm – Bordeaux (production and distribution of investigational medicinal products and devices). The Group's total permanent staff is currently 160 persons. The projected Group turnover for the coming 2013-2014 fiscal year is 25 million euros.